跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEPITEN nebivolol (as hydrochloride) 5 mg immediate release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NEPITEN nebivolol (as hydrochloride) 5 mg immediate release tablet blister pack
Approved
STANDARD
NEPITEN nebivolol (as hydrochloride) 5 mg immediate release tablet blister pack
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
514dd8063d174294
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
514dd8063d174294
Product Name
NEPITEN nebivolol (as hydrochloride) 5 mg immediate release tablet blister pack
Artg Id
311693
Artg Name
NEPITEN nebivolol (as hydrochloride) 5 mg immediate release tablet blister pack
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2020-04-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1da143a53f336933b94944fdfd2cb24a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/0cfb1a833046043d0c624fd229d72284.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
514dd8063d174294
Type
Standard
Back to TGA Approvals